These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35601360)

  • 1. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
    Suna K; Melahat UŞ; Murat Y; Figen ÖE; Ayperi Ö
    Med Clin (Engl Ed); 2022 Apr; 158(8):356-360. PubMed ID: 35601360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
    Suna K; Melahat UŞ; Murat Y; Figen ÖE; Ayperi Ö
    Med Clin (Barc); 2022 Apr; 158(8):356-360. PubMed ID: 34103164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial.
    Rodríguez-Rubio M; Figueira JC; Acuña-Castroviejo D; Borobia AM; Escames G; de la Oliva P
    Trials; 2020 Aug; 21(1):699. PubMed ID: 32758298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional parameters and outcomes in patients admitted to intensive care with COVID-19: a retrospective single-centre service evaluation.
    Eden T; McAuliffe S; Crocombe D; Neville J; Ray S
    BMJ Nutr Prev Health; 2021; 4(2):416-424. PubMed ID: 35024546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis.
    Kwak SG; Choo YJ; Chang MC
    Complement Ther Med; 2022 Mar; 64():102797. PubMed ID: 34953366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes.
    Chiodini I; Gatti D; Soranna D; Merlotti D; Mingiano C; Fassio A; Adami G; Falchetti A; Eller-Vainicher C; Rossini M; Persani L; Zambon A; Gennari L
    Front Public Health; 2021; 9():736665. PubMed ID: 35004568
    [No Abstract]   [Full Text] [Related]  

  • 15. The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients.
    Rangroo R; Young M; Davis A; Pack S; Thakore S; Schepcoff A; Oyesanmi O
    Cureus; 2022 Apr; 14(4):e24563. PubMed ID: 35664402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.
    Mahévas M; Tran VT; Roumier M; Chabrol A; Paule R; Guillaud C; Fois E; Lepeule R; Szwebel TA; Lescure FX; Schlemmer F; Matignon M; Khellaf M; Crickx E; Terrier B; Morbieu C; Legendre P; Dang J; Schoindre Y; Pawlotsky JM; Michel M; Perrodeau E; Carlier N; Roche N; de Lastours V; Ourghanlian C; Kerneis S; Ménager P; Mouthon L; Audureau E; Ravaud P; Godeau B; Gallien S; Costedoat-Chalumeau N
    BMJ; 2020 May; 369():m1844. PubMed ID: 32409486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].
    Şık N; Özlü C; Karaoğlu Asrak H; Erbaş İC; Çakıl Güzin A; Atakul G; Atay Ö; Appak Ö; Sayıner AA; Uzuner N; Asilsoy S; Belet N; Yılmaz D; Duman M
    Mikrobiyol Bul; 2020 Oct; 54(4):629-637. PubMed ID: 33107292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort Study.
    Pouwels S; Ramnarain D; Aupers E; Rutjes-Weurding L; van Oers J
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34210077
    [No Abstract]   [Full Text] [Related]  

  • 20. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
    Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
    Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.